<qa>  What is the name of the PHASE 1 STUDY to ESTABLISHAN OPEN-LABEL, MULTICENTER, MULTIPLE DOSE, PHASE 1 STUDY TO ESTABLISH THE MAXIMUM TOLERATED DOSE OF E7389 LIPOSOMAL FORMULATION IN PATIENTS WITH SOLID TUMORS: 